- Home
- MRNA vs ACI Comparison
MRNA vs ACI Comparison
Compare MRNA & ACI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | MRNA | ACI |
|---|---|---|
| Founded | 2010 | 1860 |
| Country | United States | United States |
| Employees | N/A | 270000 |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Food Chains |
| Sector | Health Care | Consumer Staples |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 11.5B | 9.3B |
| IPO Year | 2018 | 2015 |
Fundamental Metrics
Financial Performance| Metric | MRNA | ACI |
|---|---|---|
| Price | $55.54 | $17.36 |
| Analyst Decision | Hold | Buy |
| Analyst Count | 12 | 14 |
| Target Price | ★ $33.00 | $22.29 |
| AVG Volume (30 Days) | ★ 9.6M | 5.2M |
| Earning Date | 05-05-2026 | 04-07-2026 |
| Dividend Yield | N/A | ★ 3.38% |
| EPS Growth | ★ 21.77 | N/A |
| EPS | N/A | ★ 1.25 |
| Revenue | $19,263,000,000.00 | ★ $80,390,900,000.00 |
| Revenue This Year | $8.28 | $4.69 |
| Revenue Next Year | $16.53 | N/A |
| P/E Ratio | ★ N/A | $14.20 |
| Revenue Growth | ★ 4.29 | 1.46 |
| 52 Week Low | $22.28 | $15.80 |
| 52 Week High | $59.55 | $23.20 |
Technical Indicators
Market Signals| Indicator | MRNA | ACI |
|---|---|---|
| Relative Strength Index (RSI) | 63.68 | 45.56 |
| Support Level | $23.74 | $16.91 |
| Resistance Level | N/A | $17.74 |
| Average True Range (ATR) | 3.84 | 0.50 |
| MACD | 0.26 | -0.10 |
| Stochastic Oscillator | 69.97 | 23.23 |
Price Performance
Historical ComparisonAbout MRNA Moderna Inc.
Moderna is a commercial-stage biotech that was founded in 2010 and had its initial public offering in December 2018. The firm's mRNA technology was rapidly validated with its covid vaccine, which was authorized in the United States in December 2020. Moderna had 35 mRNA development candidates in clinical studies as of August 2025. Programs span a wide range of therapeutic areas, including infectious disease, oncology, cardiovascular disease, and rare genetic diseases.
About ACI Albertsons Companies Inc.
Albertsons is the second-largest supermarket operator in the United States with about 2,300 stores across a variety of banners. Around 80% of the firm's sales comes from nonperishable and fresh food, of which 26% comes from its portfolio of private brands. The company operates fuel centers at about 20% of its store locations and pharmacies at 75%. Albertsons went public in 2020 following years of ownership under private equity firm Cerberus Capital Management, which still owns about a fourth of the outstanding shares.